Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1983 1
1986 1
1987 2
1988 1
1989 1
1990 1
1992 2
1993 3
1994 2
1995 2
1997 1
1998 3
1999 3
2000 8
2001 5
2002 7
2003 4
2004 7
2005 10
2006 5
2007 3
2008 4
2009 1
2011 4
2012 2
2013 1
2014 2
2015 4
2017 2
2018 1
2019 6
2020 1
2021 3
2022 5
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension.
Freeman MW, Halvorsen YD, Marshall W, Pater M, Isaacsohn J, Pearce C, Murphy B, Alp N, Srivastava A, Bhatt DL, Brown MJ; BrigHTN Investigators. Freeman MW, et al. N Engl J Med. 2023 Feb 2;388(5):395-405. doi: 10.1056/NEJMoa2213169. Epub 2022 Nov 7. N Engl J Med. 2023. PMID: 36342143 Clinical Trial.
Results from a phase 1, randomized, double-blind, multiple ascending dose study characterizing the pharmacokinetics and demonstrating the safety and selectivity of the aldosterone synthase inhibitor baxdrostat in healthy volunteers.
Freeman MW, Bond M, Murphy B, Hui J, Isaacsohn J. Freeman MW, et al. Hypertens Res. 2023 Jan;46(1):108-118. doi: 10.1038/s41440-022-01070-4. Epub 2022 Oct 20. Hypertens Res. 2023. PMID: 36266539 Free PMC article. Clinical Trial.
Postmenopausal hormone-replacement therapy.
Martin KA, Freeman MW. Martin KA, et al. Among authors: freeman mw. N Engl J Med. 1993 Apr 15;328(15):1115-7. doi: 10.1056/NEJM199304153281509. N Engl J Med. 1993. PMID: 8455670 No abstract available.
Macrophage scavenger receptors.
Freeman MW. Freeman MW. Curr Opin Lipidol. 1994 Apr;5(2):143-8. doi: 10.1097/00041433-199404000-00011. Curr Opin Lipidol. 1994. PMID: 8044417 Review.
Scavenger receptors in atherosclerosis.
Freeman MW. Freeman MW. Curr Opin Hematol. 1997 Jan;4(1):41-7. doi: 10.1097/00062752-199704010-00007. Curr Opin Hematol. 1997. PMID: 9050378 Review.
Atherosclerosis and innate immune signaling.
Laberge MA, Moore KJ, Freeman MW. Laberge MA, et al. Among authors: freeman mw. Ann Med. 2005;37(2):130-40. doi: 10.1080/07853890510007304. Ann Med. 2005. PMID: 16026120 Review.
106 results